A Texas CEO Just Got Four Years for Addiction-Treatment Billing: Why Florida Treatment Centers and Sober Homes Are Next
Listen to Article
Part 1: A Texas CEO Just Got Four Years for Addiction-Treatment Billing: Why Florida Treatment Centers and Sober Homes Are Next
A Kentucky jury convicted three addiction-treatment operators and the CEO drew 48 months. Florida treatment centers and sober homes are the next federal target.
The Justice Department has now finished sentencing the people who ran a chain of Kentucky addiction-treatment clinics, and the numbers should get the attention of every treatment center and sober home operator in Florida. The chief executive, a Texas businessman, received 48 months in federal prison this month. The clinics' medical director received 60 months earlier this year. The billing manager received 24. A jury convicted all three of fraudulently billing Medicare and Kentucky Medicaid more than $8 million for addiction-treatment services that were never provided as billed. If you operate in the recovery industry in Florida, this is not a Kentucky story. It is a preview of where federal enforcement is headed, and Florida is where the government has always tested its addiction-treatment cases first.
A federal jury in the Eastern District of Kentucky convicted three operators of Kentucky Addiction Centers of billing Medicare and Kentucky Medicaid more than $8 million for addiction-treatment services that were not provided as represented. The sentences came in stages: 24 months for the billing manager, 60 months for the medical director, and 48 months this month for the chief executive. Core exposure runs through 18 U.S.C. § 1347 health care fraud and § 1349 conspiracy, each carrying up to 10 years per count. Florida operators face the same federal theory plus EKRA, 18 U.S.C. § 220, the state Patient Brokering Act, Fla. Stat. § 817.505, and Florida Medicaid fraud, Fla. Stat. § 409.920.

The Kentucky convictions are not a Kentucky story. Florida is where the government has always tested its addiction-treatment cases first.
Key Takeaways
- A federal jury conviction for addiction-treatment billing fraud produced prison sentences of 24 to 60 months, even with restitution far below the amount billed.
- Core exposure runs through 18 U.S.C. § 1347 health care fraud and § 1349 conspiracy, each carrying up to 10 years per count.
- EKRA, 18 U.S.C. § 220, criminalizes kickbacks for referrals to recovery homes and clinical treatment facilities, and reaches private insurance, not just federal programs.
- Florida operators face parallel state exposure under the Patient Brokering Act, Fla. Stat. § 817.505, and Florida Medicaid fraud, Fla. Stat. § 409.920.
- South Florida, and Palm Beach County in particular, remains the most heavily scrutinized recovery-industry market in the country.
What Actually Happened in the Kentucky Addiction Centers Case
A federal jury in the Eastern District of Kentucky convicted three people who ran Kentucky Addiction Centers, a chain of outpatient addiction-treatment clinics operating in Winchester, Paducah, Paintsville, and London. According to the Justice Department's announcement of the verdict, the clinics billed Medicare and Kentucky Medicaid more than $8 million for addiction-treatment services, including physician visits and therapy connected to Suboxone-based treatment, that were not provided as represented. The HHS Office of Inspector General worked the case alongside DOJ, which is the standard configuration in these prosecutions.
Three details matter more than the headline. First, this was a trial conviction, not a plea. The government took an addiction-treatment billing case to a jury and won across the board. Second, the sentences came down in stages, 24 months for the billing manager, 60 months for the medical director, and now 48 months for the chief executive, which tells you the government pursued everyone in the management chain, not just the physician. Third, the court ordered restitution of roughly $813,000 against more than $8 million billed. The defense fight over actual loss versus billed amounts clearly mattered, and it always does.

Why Addiction Treatment Is Now a Front-Line Federal Target
Addiction treatment sits at the intersection of two things the government cares about most right now: opioid-crisis politics and program-integrity data. The 2026 National Health Care Fraud Takedown charged 455 defendants in schemes involving more than $6.5 billion in alleged false claims, and behavioral health and substance-abuse treatment billing featured heavily in the charging mix. CMS data analytics now flag treatment providers whose therapy hours, urine drug screens, or physician-visit counts are statistically impossible, and those referrals move from audit to criminal investigation faster than most operators realize. A Medicare audit turned criminal is the most common origin story in this practice area.
Florida is not a bystander here. Palm Beach County built the sober home enforcement model that the rest of the country copied, and state prosecutors have run patient-brokering cases against recovery residences and treatment centers for nearly a decade. Federal prosecutors in the Southern District of Florida and the Middle District of Florida have the Medicare Strike Force infrastructure, the data, and the appetite. When a national enforcement theme emerges, South Florida is where it lands first and hardest.

The Statutes and the Real Exposure
The core federal charge is health care fraud under 18 U.S.C. § 1347, with conspiracy under 18 U.S.C. § 1349. Each count carries up to 10 years, and 20 where serious bodily injury results. The recovery industry also has its own dedicated kickback statute: EKRA, 18 U.S.C. § 220, which criminalizes paying or receiving anything of value for referrals to recovery homes, clinical treatment facilities, or laboratories. EKRA reaches private-pay and commercially insured patients, which surprises operators who assumed only federal programs created risk. The traditional Anti-Kickback Statute, 42 U.S.C. § 1320a-7b, still applies to Medicare and Medicaid referrals, and physicians who prescribe Suboxone or other controlled substances outside the usual course of professional practice face separate exposure under 21 U.S.C. § 841. Any physician in this position needs a doctor controlled substance defense strategy and a DEA registrant defense posture from day one.
Florida adds its own layer. The Patient Brokering Act, Fla. Stat. § 817.505, makes referral payments a third-degree felony per patient, and Florida Medicaid fraud under Fla. Stat. § 409.920 runs parallel to any federal case. On the federal side, sentencing exposure is driven by the loss table in the U.S. Sentencing Guidelines. The gap between what a clinic billed and what the programs actually paid is often the difference between a probation argument and a decade of exposure, which is why loss litigation belongs at the center of any defense plan, not at the end of it.
EKRA, 18 U.S.C. § 220, reaches referrals to recovery homes and clinical treatment facilities regardless of payor, including private insurance and cash-pay patients. That is what makes it broader than the Anti-Kickback Statute, and why a Florida sober home with no Medicare billing is still exposed.

The Mistakes Operators Make Before They Ever Call a Lawyer
The same errors appear in nearly every one of these cases. Operators treat a ZPIC audit, UPIC audit, or records request as a billing department problem and respond without counsel. They sit for friendly interviews when HHS-OIG agents appear at the clinic, confident they can explain the billing. They produce documents piecemeal, without a litigation hold or a strategy, and create a false-statement record along the way. They assume that because no charges have been filed, the matter is administrative. And they wait for an indictment before hiring a federal criminal defense attorney, which forfeits the only stage of the case where outcomes are genuinely fluid.
Staff interviews deserve their own warning. Billing managers, therapists, and front-desk employees are usually interviewed before the owner ever knows an investigation exists. The Kentucky case shows the government's working theory: the billing manager, the physician, and the executive are all chargeable, so everyone in that chain needs to understand their own exposure before they talk to anyone.
Treat any audit of addiction-treatment billing as potential criminal exposure. Put a litigation hold in place, route every records request through counsel, and make sure billing managers, therapists, and front-desk staff understand their own exposure before agents interview them.
What a Serious Defense Looks Like
Pre-indictment defense work decides these cases. Counsel who enters at the audit or subpoena stage can manage the parallel administrative and criminal tracks, run a privileged internal review of the billing conduct, and engage prosecutors while the charging decision is still open. Sometimes the right move is a declination pitch built on billing-error evidence and compliance history. Sometimes it is a carefully negotiated civil resolution that keeps the case out of the criminal system. A proffer can be the right tool or a trap, and the decision requires a proffer agreement defense lawyer who has sat on both sides of that table. If charges do come, the Kentucky sentences show the range that effective loss and role arguments can produce even after a trial loss.

"An operator who responds to the first government contact with experienced federal investigation defense counsel has options that disappear entirely once the indictment is returned."— Aaron M. Cohen, Principal Attorney
Why the Window Is Closing Faster Than It Looks
These investigations run for years before anyone is charged, and the staggered sentencing dates in the Kentucky case reflect that timeline. But the decisions that determine the outcome happen early. CMS can suspend payments on a credible allegation of fraud, which ends most treatment businesses before any court ever weighs the evidence. Grand jury subpoenas to referral sources and labs signal the direction of the case months before a target letter arrives. An operator who responds to the first government contact with experienced federal investigation defense counsel has options that disappear entirely once the indictment is returned. In this practice area, timing is not a cliché. It is the whole game.
Common Questions
For the broader Florida enforcement landscape, see our overview of sober home and addiction treatment fraud in South Florida.
AMC Defense Law is a federal healthcare fraud and white collar defense practice representing treatment centers, recovery residences, physicians, and executives in federal and state investigations across Florida and nationwide, from the first audit letter through trial and sentencing. If your clinic has received a subpoena, an audit notice, or a visit from federal agents, the conversation should happen now, while the outcome can still be shaped.

AMC Defense Law defends treatment centers, recovery residences, physicians, and executives in federal and state healthcare fraud investigations across Florida and nationwide.
If you or your loved ones have been arrested or are under investigation in a healthcare fraud matter, call Aaron M. Cohen, 24 hours a day to get help.
This article is for informational purposes only and does not constitute legal advice. No attorney-client relationship is formed by reading this content.
Listen to Article
Part 1: A Texas CEO Just Got Four Years for Addiction-Treatment Billing: Why Florida Treatment Centers and Sober Homes Are Next
A Kentucky jury convicted three addiction-treatment operators and the CEO drew 48 months. Florida treatment centers and sober homes are the next federal target.

Aaron M. Cohen
Principal Attorney
Aaron M. Cohen is a nationally recognized criminal defense attorney with over 30 years of experience representing individuals and entities in complex criminal investigations and prosecutions across the United States.
View Attorney ProfileRelated Analysis
Free Heart Screens, Phantom Diagnoses: Why Federal Prosecutors Are Targeting Florida Cardiology and Diagnostic-Testing Practices
A South Florida cardiology operation billed $89M using free heart checks that produced diagnoses patients never had. The 2026 takedown shows how prosecutors build these cases and why the pre-indictment window is the only one that matters.
The 2026 DOJ Health Care Fraud Takedown: What South Florida Providers and Targets Need to Know Now
The DOJ charged 455 defendants including 90 medical professionals in a $6.5B coordinated sweep. Data analytics now opens cases before a whistleblower does. What South Florida providers need to know.
Clinical Trial Data Fraud in South Florida: What Research Sites Need to Know
FDA charged another South Florida research site with fabricating clinical trial data. Wire fraud exposure, real sentences, and what anyone connected to a research site needs to do right now.